These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 32226527)
1. Effective delivery of mycophenolic acid by oxygen nanobubbles for modulating immunosuppression. Khan MS; Kim JS; Hwang J; Choi Y; Lee K; Kwon Y; Jang J; Yoon S; Yang CS; Choi J Theranostics; 2020; 10(9):3892-3904. PubMed ID: 32226527 [TBL] [Abstract][Full Text] [Related]
2. Effective delivery of immunosuppressive drug molecules by silica coated iron oxide nanoparticles. Hwang J; Lee E; Kim J; Seo Y; Lee KH; Hong JW; Gilad AA; Park H; Choi J Colloids Surf B Biointerfaces; 2016 Jun; 142():290-296. PubMed ID: 26966999 [TBL] [Abstract][Full Text] [Related]
3. Polysaccharide mycophenolate-based nanoparticles for enhanced immunosuppression and treatment of immune-mediated inflammatory diseases. Li Y; Lou Y; Chen Y; Yang J; Li D; Jiang B; Lan J; Wen J; Fu Y; Zhang Y; Tao J; Zhu J Theranostics; 2021; 11(8):3694-3709. PubMed ID: 33664856 [TBL] [Abstract][Full Text] [Related]
4. Surface Composition and Preparation Method for Oxygen Nanobubbles for Drug Delivery and Ultrasound Imaging Applications. Khan MS; Hwang J; Lee K; Choi Y; Jang J; Kwon Y; Hong JW; Choi J Nanomaterials (Basel); 2019 Jan; 9(1):. PubMed ID: 30609703 [TBL] [Abstract][Full Text] [Related]
5. Enteric-coated mycophenolate sodium for transplant immunosuppression. Ingle GR; Shah T Am J Health Syst Pharm; 2005 Nov; 62(21):2252-9. PubMed ID: 16239415 [TBL] [Abstract][Full Text] [Related]
6. Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update. Staatz CE; Tett SE Arch Toxicol; 2014 Jul; 88(7):1351-89. PubMed ID: 24792322 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic, pharmacodynamic, and outcome investigations as the basis for mycophenolic acid therapeutic drug monitoring in renal and heart transplant patients. Shaw LM; Korecka M; DeNofrio D; Brayman KL Clin Biochem; 2001 Feb; 34(1):17-22. PubMed ID: 11239510 [TBL] [Abstract][Full Text] [Related]
8. In vitro effects of mycophenolic acid on the nucleotide pool and on the expression of adhesion molecules of human umbilical vein endothelial cells. Raab M; Daxecker H; Karimi A; Markovic S; Cichna M; Markl P; Müller MM Clin Chim Acta; 2001 Aug; 310(1):89-98. PubMed ID: 11485760 [TBL] [Abstract][Full Text] [Related]
9. Mycophenolic acid concentrations in peripheral blood mononuclear cells are associated with the incidence of rejection in renal transplant recipients. Md Dom ZI; Coller JK; Carroll RP; Tuke J; McWhinney BC; Somogyi AA; Sallustio BC Br J Clin Pharmacol; 2018 Oct; 84(10):2433-2442. PubMed ID: 29974488 [TBL] [Abstract][Full Text] [Related]
10. Mycophenolic acid quantification in human peripheral blood mononuclear cells using liquid chromatography-tandem mass spectrometry. Nguyen Thi MT; Capron A; Mourad M; Wallemacq P Clin Biochem; 2013 Dec; 46(18):1909-11. PubMed ID: 24060731 [TBL] [Abstract][Full Text] [Related]
11. Assessment of mycophenolic acid-induced immunosuppression: a new approach. Millan O; Oppenheimer F; Brunet M; Vilardell J; Rojo I; Vives J; Martorell J Clin Chem; 2000 Sep; 46(9):1376-83. PubMed ID: 10973868 [TBL] [Abstract][Full Text] [Related]
12. Macrophage lipid accumulation in the presence of immunosuppressive drugs mycophenolate mofetil and cyclosporin A. Voloshyna I; Teboul I; Kasselman LJ; Salama M; Carsons SE; DeLeon J; Mattana J; Miyawaki N; Reiss AB Inflamm Res; 2019 Sep; 68(9):787-799. PubMed ID: 31227843 [TBL] [Abstract][Full Text] [Related]
13. Mycophenolic acid inhibits SLE-associated cytokine expression and promotes apoptosis of peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Su DL; Wang HJ; Ji XH; Li YY; Xuan HB; Heng C; Li YF Acta Pharmacol Sin; 2006 Aug; 27(8):1051-7. PubMed ID: 16867258 [TBL] [Abstract][Full Text] [Related]
14. Mycophenolate mofetil and its mechanisms of action. Allison AC; Eugui EM Immunopharmacology; 2000 May; 47(2-3):85-118. PubMed ID: 10878285 [TBL] [Abstract][Full Text] [Related]
15. Mycophenolic acid and 6-mercaptopurine both inhibit B-cell proliferation in granulomatosis with polyangiitis patients, whereas only mycophenolic acid inhibits B-cell IL-6 production. von Borstel A; Abdulahad WH; Dekkema G; Rutgers A; Stegeman CA; Veldman J; Heeringa P; Sanders JS PLoS One; 2020; 15(7):e0235743. PubMed ID: 32645052 [TBL] [Abstract][Full Text] [Related]
16. Rediscovering mycophenolic acid: a review of its mechanism, side effects, and potential uses. Kitchin JE; Pomeranz MK; Pak G; Washenik K; Shupack JL J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):445-9. PubMed ID: 9308561 [TBL] [Abstract][Full Text] [Related]
17. Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF). Allison AC; Eugui EM Clin Transplant; 1996 Feb; 10(1 Pt 2):77-84. PubMed ID: 8680053 [TBL] [Abstract][Full Text] [Related]
18. Determination of the effects of mycophenolic acid on the nucleotide pool of human peripheral blood mononuclear cells in vitro by high-performance liquid chromatography. Daxecker H; Raab M; Cichna M; Markl P; Müller MM Clin Chim Acta; 2001 Aug; 310(1):81-7. PubMed ID: 11485759 [TBL] [Abstract][Full Text] [Related]